Zymeworks Stock Rises on Partnership

Zymeworks' stock experienced an increase following the announcement of a new partnership with Gandeeva. This collaboration focuses on leveraging Gandeeva's cryo-EM technology to advance Zymeworks' drug discovery and development programs. The partnership is anticipated to accelerate the identification and optimization of novel therapeutic candidates, potentially leading to significant breakthroughs in Zymeworks' pipeline and enhancing its overall research capabilities.